PCI The Journeys Within
CPHI 2026 – 23/07/2026
Media Pack
News

Current Edition

JCS - Volume 18 Issue 3 - Autumn 2026
Frankfurt 2027 – 12/10/26
ramusmedical
Europe

Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen

First commercial program under Bavarian Nordic and Janssen Vaccines & Prevention B.V. collaboration advancing into clinical trialsA therapeutic vaccine may repre...
28 February 2019 Europe | news | Regional News
Continue Reading →
news

Offering Merck’s experimental Ebola vaccine to pregnant women is a risky but necessary move, says GlobalData

Following the recent announcement from the WHO that Merck’s experimental Ebola vaccine V920 (rVSV-ZEBOV) will be offered to pregnant women in the Congo for the first...
28 February 2019 news | Regional News | Sub Saharan Africa
Continue Reading →
Europe

Clinerion partners with MEDSOFT on expanding clinical research in Georgia.

Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical studies and the use of Patient Network Explorer for academi...
28 February 2019 Europe | news | Regional News
Continue Reading →
Europe

Setting Standards: Achieving Workforce Excellence

New Case Study Unveils Successful Approach to Enhancing Clinical Research Processes Maidenhead, 27 February 2019 -- New steps to achieving clinical research workfo...
28 February 2019 Europe | news | North America | Regional News
Continue Reading →
Europe

Minoryx Therapeutics receives approval from Spanish Regulatory Agency to initiate phase 2 study in Friedreich’s Ataxia

FRAMES trial expected to initiate patient recruitment in upcoming weeks in Spain, Belgium and other European countriesProfessor Alexandra Durr, principal investigato...
28 February 2019 Europe | news | Regional News
Continue Reading →
news

Clinical trial researchers can initiate advance care planning discussions to help cancer patients

Cancer clinical trials are an important option for patients with cancer. Yet, once a trial ends, patients still need care plans. Little is known at what point during...
20 February 2019 news | North America | Regional News
Continue Reading →
Europe

With positive phase 3, Intercept to file NASH drug for approval while Inventiva faces a setback

In a crowded field of nonalcoholic steatohepatitis (NASH) hopefuls, Intercept Pharmaceuticals looks to be pulling ahead. In a pivotal phase 3 study, the biotech’s ob...
20 February 2019 Europe | news | Regional News
Continue Reading →
news

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announce first of its kind collaboration to integrate blockchain technology into clinical trials

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, the...
20 February 2019 news | North America | Regional News
Continue Reading →
news

Use of clinical apps significantly improves quality of cardiovascular care

A pilot program using several clinical decision support tools in the outpatient setting to treat and educate stable ischemic heart disease patients has shown succes...
20 February 2019 news | North America | Regional News
Continue Reading →
news

Ochsner Health System and Pfizer partner to develop innovative models for clinical trials

NEW ORLEANS & Ochsner Health System, Louisiana's largest non-profit academic healthcare system, and Pfizer Inc (NYSE:PFE) have entered into a multi-year strateg...
20 February 2019 news | North America | Regional News
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte